Clinical features and multidisciplinary treatment outcome of COVID-19 pneumonia: A report of three cases

被引:5
作者
Liu, Chun [1 ]
Wu, Changhui [1 ]
Zheng, Xiangde [1 ]
Zeng, Fanwei [2 ]
Liu, Jinping [3 ]
Wang, Pingxi [2 ]
Zeng, Fanxin [4 ]
Yuan, Lin [5 ]
Zhu, Fangcheng [6 ]
Gan, Xuemei [6 ]
Huang, Yucheng [7 ]
机构
[1] Dazhou Cent Hosp, Dept Crit Care Med, 151 Dadong St, Dazhou 635000, Sichuan, Peoples R China
[2] Dazhou Cent Hosp, Dept Orthoped, Dazhou, Sichuan, Peoples R China
[3] Dazhou Vocat Coll Chinese Med, Dazhou, Sichuan, Peoples R China
[4] Dazhou Cent Hosp, Clin Res Ctr, Dazhou, Sichuan, Peoples R China
[5] Dazhou Cent Hosp, Dept Nutr, Dazhou, Sichuan, Peoples R China
[6] Dazhou Cent Hosp, Dept Infect Dis, Dazhou, Sichuan, Peoples R China
[7] Dazhou Cent Hosp, Dept Radiol, Dazhou, Sichuan, Peoples R China
关键词
COVID-19; SARS-CoV-2; Multidisciplinary therapeutic approach; CORONAVIRUS;
D O I
10.1016/j.jfma.2020.04.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic threatening global public health. In the current paper, we describe our successful treatment of three COVID-19 pneumonia patients cases including severe cases and cases with mortality risk factors. One 32-year-old male COVID-19 patient was diagnosed with severe COVID-19 pneumonia and moderate ARDS. The second COVID-19 pneumonia patient had a history of diabetes and chronic bronchitis. The third case of COVID-19 pneumonia was an 82-year old female patient. All three cases had severe COVID pneumonia and therefore were aggressively managed with a multidisciplinary and personalized therapeutic approach that included nutritional support, antiviral pharmacotherapy, active control of comorbidities, prevention of complication development and psychological intervention. Our experience highlights the importance of the use of a multidisciplinary therapeutic approach that tailors to the specific condition of the patient in achieving a favorable clinical outcome. Copyright (C) 2020, Formosan Medical Association. Published by Elsevier Taiwan LLC.
引用
收藏
页码:1702 / 1709
页数:8
相关论文
共 15 条
  • [1] [Anonymous], 2020, Zhonghua Yi Xue Za Zhi, DOI DOI 10.3760/CMA.J.CN112137-20200205-00199
  • [2] [Anonymous], 2020, UN WHO Situation Report-51
  • [3] The 2019 novel coronavirus disease (COVID-19) pandemic: A zoonotic prospective
    Chakraborty, Chiranjib
    Sharma, Ashish Ranjan
    Bhattacharya, Manojit
    Sharma, Garima
    Lee, Sang-Soo
    [J]. ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2020, 13 (06) : 242 - 246
  • [4] Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
    Channappanavar, Rudragouda
    Perlman, Stanley
    [J]. SEMINARS IN IMMUNOPATHOLOGY, 2017, 39 (05) : 529 - 539
  • [6] Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China (vol 395, pg 497, 2020)
    Huang, C.
    Wang, Y.
    Li, X.
    [J]. LANCET, 2020, 395 (10223) : 496 - 496
  • [7] Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome
    Jiang, Y
    Xu, J
    Zhou, CZ
    Wu, ZG
    Zhong, SQ
    Liu, JH
    Luo, W
    Chen, T
    Qin, QH
    Deng, P
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (08) : 850 - 857
  • [8] COVID-19 pneumonia in Taiwan
    Joob, Beuy
    Wiwanitkit, Viroj
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (05) : 998 - 998
  • [9] MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
    Mahallawi, Waleed H.
    Khabour, Omar F.
    Zhang, Qibo
    Makhdoum, Hatim M.
    Suliman, Bandar A.
    [J]. CYTOKINE, 2018, 104 : 8 - 13